Nov 21, 2024
In this episode, host Shikha Jain, MD, speaks
with Melody Harris about the evolution of
precision medicine, what physicians and companies can do to help
patients better understand precision oncology and more.
• Welcome to another exciting episode of Oncology
Overdrive 0:14
• About Harris 0:20
• The interview 1:11
• Tell us about how you ended up in this niche role.
1:32
• How did you make the decision to move from
practicing law to transitioning your career into this space?
3:56
• Jain and Harris on the “hype” around precision
medicine. 7:11
• What is the central thesis of the work at
NeoGenomics? 10:36
• What do you feel companies need to be doing to make
expectations surrounding diagnoses more transparent for patients?
11:49
• Where do you think this is all going in the future?
Where do you think we’ll be in another ten or twenty years?
13:30
• What do you see yourself doing next?
19:04
• How can companies address the disparities in health
care access, especially in underserved areas?
21:06
• If someone could only listen to the last few minutes
of this episode, what would you want listeners to take away?
23:32
• How to contact Harris
24:30
• Thanks for listening
25:14
Melody Harris serves as chief operations officer
and president of informatics at NeoGenomics, a leading oncology
testing services company.
We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Harris can be reached at melody.harris@neogenomics.com.
Disclosures: Jain and Harris report no relevant financial disclosures.